1. Home
  2. AGIO vs HI Comparison

AGIO vs HI Comparison

Compare AGIO & HI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AGIO
  • HI
  • Stock Information
  • Founded
  • AGIO 2007
  • HI 2007
  • Country
  • AGIO United States
  • HI United States
  • Employees
  • AGIO N/A
  • HI N/A
  • Industry
  • AGIO Biotechnology: Pharmaceutical Preparations
  • HI Miscellaneous manufacturing industries
  • Sector
  • AGIO Health Care
  • HI Consumer Discretionary
  • Exchange
  • AGIO Nasdaq
  • HI Nasdaq
  • Market Cap
  • AGIO 1.4B
  • HI 1.4B
  • IPO Year
  • AGIO 2013
  • HI N/A
  • Fundamental
  • Price
  • AGIO $39.23
  • HI $22.28
  • Analyst Decision
  • AGIO Buy
  • HI Hold
  • Analyst Count
  • AGIO 6
  • HI 2
  • Target Price
  • AGIO $58.60
  • HI $24.00
  • AVG Volume (30 Days)
  • AGIO 615.0K
  • HI 533.8K
  • Earning Date
  • AGIO 07-31-2025
  • HI 08-06-2025
  • Dividend Yield
  • AGIO N/A
  • HI 4.04%
  • EPS Growth
  • AGIO N/A
  • HI N/A
  • EPS
  • AGIO 11.45
  • HI N/A
  • Revenue
  • AGIO $37,035,000.00
  • HI $3,047,000,000.00
  • Revenue This Year
  • AGIO $22.30
  • HI N/A
  • Revenue Next Year
  • AGIO $219.19
  • HI N/A
  • P/E Ratio
  • AGIO $3.39
  • HI N/A
  • Revenue Growth
  • AGIO 25.96
  • HI 0.30
  • 52 Week Low
  • AGIO $23.42
  • HI $18.36
  • 52 Week High
  • AGIO $62.58
  • HI $45.53
  • Technical
  • Relative Strength Index (RSI)
  • AGIO 70.51
  • HI 56.38
  • Support Level
  • AGIO $34.60
  • HI $21.94
  • Resistance Level
  • AGIO $40.06
  • HI $23.60
  • Average True Range (ATR)
  • AGIO 1.45
  • HI 0.87
  • MACD
  • AGIO 0.43
  • HI 0.22
  • Stochastic Oscillator
  • AGIO 88.98
  • HI 68.87

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

About HI Hillenbrand Inc

Hillenbrand Inc is a industrial company that provides engineered processing equipment and solutions to customers around the world. The company operates through two segments. The Advanced Process Solutions segment designs, develops, manufactures, and services engineered industrial equipment and also provider of engineered process and material handling equipment, systems, and aftermarket parts and services for a variety of industries, including durable plastics, food, and recycling. Molding Technology Solutions has a comprehensive product portfolio that includes injection molding and extrusion equipment, It earns it revenue from Advanced Process Solutions, and Geographically from America, following by Asia and EMEA.

Share on Social Networks: